A Visible-Light-Active CuS/MoS2/Bi2WO6 Aptamer Sensitively Detects the Non-Steroidal Anti-Inflammatory Drug Diclofenac

Nanomaterials (Basel). 2022 Aug 18;12(16):2834. doi: 10.3390/nano12162834.

Abstract

Diclofenac is a non-steroidal, anti-inflammatory drug and is clinically used for the treatment of osteoarthritis, non-articular rheumatism, etc. This research aimed to demonstrate the creation of an upgraded photoelectrochemical (PEC) aptamer sensor for detecting diclofenac (DCF) with high sensitivity. In this work, photoactive materials and bio-identification components served as visible-light-active CuS/MoS2/Bi2WO6 heterostructures and aptamers, respectively. CuS and MoS2/Bi2WO6 were combined to improve photocurrent responsiveness, which helped the structure of PEC aptasensors. Additionally, the one-pot synthesis of CuS/MoS2/Bi2WO6 was ecologically beneficial. With these optimizations, the photocurrent response of aptamer/CS/CuS/MoS2/Bi2WO6 exhibited linearity between 0.1 and 500 nM DCF. The detection limit was 0.03 nM (S/N = 3). These results suggest that the PEC sensing technique might produce an ultra-sensitive sensor with high selectivity and stability for DCF detection.

Keywords: CuS/MoS2/Bi2WO6; aptasensors; diclofenac (DFC); heterostructure; photoelectrochemical.